Grant Awarded to Commercialize a Revolutionary Modular Neurostimulation System Designed to Address Neurological Conditions and Injuries Read the full article here
Neurodevice firm SPR Therapeutics has received the CE mark for its Smartpatch system, a peripheral nerve stimulation (PNS) therapy for the minimally-invasive treatment of pain. Read the full article here
Neurodevice firm SPR™ Therapeutics has raised $5 million in Series A financing from NDI Healthcare Fund, Public Square Partners, and individual investors. Read the full article here
Want to stay informed?
Get the latest on patient success cases, studies, training webinars and more delivered to your inbox.